Assuming test is required, the following results were found.

  • Central Michigan Hospital plots leadership path in MS research (Blood testing for MS, NeuroFilaments and more)

    Memorial Healthcare's neurology department is growing and engaged in cutting-edge research New blood tests for MS patients are being tested that will help doctors pinpoint stage of disease and best drug to slow debilitating effects Multi-disciplinary...

    https://mschristian.org/index.php/blog/central-michigan-hospital-plots-leadership-path-in-ms-research-blood-testing-for-ms-neurofilaments-and-more
  • New app offers faster and easier assessment for multiple sclerosis

    paper-based assessment tool, researchers say they found that the app produced highly accurate results while reducing test time from about 23 to 14 minutes. Study results are described in the July 2019 online issue of the International Journal of MS...

    https://mschristian.org/index.php/blog/new-app-offers-faster-and-easier-assessment-for-multiple-sclerosis
  • New app offers faster and easier assessment for multiple sclerosis

    paper-based assessment tool, researchers say they found that the app produced highly accurate results while reducing test time from about 23 to 14 minutes. Study results are described in the July 2019 online issue of the International Journal of MS...

    https://mschristian.org/index.php/articles/2-uncategorised/8543-new-app-offers-faster-and-easier-assessment-for-multiple-sclerosis
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    (n = 3). (C) IFN scores (RT-PCR) of patients, parents, and n = 29 healthy controls. ****P...

    https://mschristian.org/index.php/articles/2-uncategorised/9542-severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 - Science

    (n = 3). (C) IFN scores (RT-PCR) of patients, parents, and n = 29 healthy controls. ****P...

    https://mschristian.org/index.php/blog/severe-type-i-interferonopathy-and-unrestrained-interferon-signaling-due-to-a-homozygous-germline-mutation-in-stat2-science
  • Dementia Life Expectancy; Teens and Opioids; Duchenne Test for Newborns

    in a phase I study, COMPASS Pathways and King's College London said. Can green lights ease migraine? (NPR) The first test to help screen newborn babies for Duchenne muscular dystrophy won FDA approval. A phase III study of amantadine (ADS-5102) for MS...

    https://mschristian.org/index.php/articles/2-uncategorised/9614-dementia-life-expectancy-teens-and-opioids-duchenne-test-for-newborns
  • Aubagio (teriflunomide)

    of these drugs is Arava (leflunomide), which is prescribed to treat rheumatoid arthritis. Your doctor will give you blood tests before and while you take Aubagio to check your liver. Risk of birth defects. If you're pregnant, you shouldn't take Aubagio...

    https://mschristian.org/index.php/articles/2-uncategorised/8433-aubagio-teriflunomide
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest advancements in diagnosis and treatment of multiple sclerosis (MS) proves challenging. Many neurologists—even those who spend...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Aubagio (teriflunomide)

    of these drugs is Arava (leflunomide), which is prescribed to treat rheumatoid arthritis. Your doctor will give you blood tests before and while you take Aubagio to check your liver.Risk of birth defects. If you're pregnant, you shouldn't take Aubagio...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide
  • Education level and socioeconomic status can predict thinking and memory performance

    Reviewed by James Ives, M.Psych. (Editor)Oct 31 2019 How well eight-year-olds score on a test of thinking skills may be a predictor of how they will perform on tests of thinking and memory skills when they are 70 years old, according to a study...

    https://mschristian.org/index.php/articles/2-uncategorised/9100-education-level-and-socioeconomic-status-can-predict-thinking-and-memory-performance
  • Hospitals to Test Music-Based mHealth Platform for Stroke Treatment - mHealthIntelligence.com

    By Eric Wicklund October 29, 2019 - Five rehabilitation hospitals will be testing a telehealth platform for stroke treatment that integrates music with AI and mHealth sensors for guided therapy. The hospitals will be testing a digital therapeutic...

    https://mschristian.org/index.php/articles/2-uncategorised/9074-hospitals-to-test-music-based-mhealth-platform-for-stroke-treatment-mhealthintelligence-com
  • Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

    Press Release ZEPOSIA is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation* 1,2,3 ZEPOSIA 360 Support™ Program offers support to help appropriate MS patients access...

    https://mschristian.org/index.php/bristol-myers-squibb-announces-commercial-launch-and-availability-of-zeposia-ozanimod-a-new-oral-treatment-for-relapsing-forms-of-multiple-sclerosis
  • Diagnosis and Symptoms of Secondary Progressive MS

    In SPMS, symptoms and disability gradually increase over time without remissions. Your doctor will examine you and do tests to find out whether you still have RRMS or you've moved on to SPMS. If you have made the shift to the new stage, a few changes to...

    https://mschristian.org/index.php/blog/diagnosis-and-symptoms-of-secondary-progressive-ms
  • New technology to monitor anti-drug antibodies in MS patients may have potential for COVID-19 testing

    treatment failure. The researchers say that they have also applied the technology to COVID-19 for potential use in antibody testing to determine whether someone has previously been infected with the virus. Antibodies are proteins that are made by the...

    https://mschristian.org/index.php/new-technology-to-monitor-anti-drug-antibodies-in-ms-patients-may-have-potential-for-covid-19-testing
  • Researchers develop novel method to diagnose and monitor autoimmune disorders

    the treatment of autoimmune diseases is substantially complicated due to dramatic variations in the results of commercial tests by different manufacturers. "Depending on the laboratory running the test, and the method used, the autoantibody...

    https://mschristian.org/index.php/researchers-develop-novel-method-to-diagnose-and-monitor-autoimmune-disorders
  • Researchers develop novel method to diagnose and monitor autoimmune disorders

    the treatment of autoimmune diseases is substantially complicated due to dramatic variations in the results of commercial tests by different manufacturers. "Depending on the laboratory running the test, and the method used, the autoantibody...

    https://mschristian.org/index.php/articles/2-uncategorised/10817-researchers-develop-novel-method-to-diagnose-and-monitor-autoimmune-disorders
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    MD Published: December 02, 2019 As the field of neuroimmunology evolves at an unprecedented rate, keeping up with the latest advancements in diagnosis and treatment of multiple sclerosis (MS) proves challenging. Many neurologists—even those who spend...

    https://mschristian.org/index.php/articles/2-uncategorised/9438-treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Potential genetic markers of multiple sclerosis severity

    samples from the patients to collect their DNA, the researchers hunted for genetic mutations in those people with the fastest deterioration rates and identified 23 such DNA variations that mapped to the complement gene C3. Next, to search for genes...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • About MRIs and Other Scans - How Does Radiology Help Diagnose MS?

    disease progression. An MRI can provide different information, depending on how it’s done. Types of MRI and radiology tests that may be used for MS include: T1-weighted brain MRI. Using contrast dye to detect active inflammation, this scan highlights...

    https://mschristian.org/index.php/blog/about-mris-and-other-scans-how-does-radiology-help-diagnose-ms
  • Four-Year Study Confirms That Imaging the Eye with OCT Provides Window to MS Progression in the Brain and a Way to Track the Effects of Therapies

    Optical coherence tomography (OCT) is a non-invasive imaging test. OCT uses light waves to take cross-section pictures of your retina. So, what is OCT imaging? Optical coherence tomography (OCT) is a non-invasive imaging test. OCT uses light waves to...

    https://mschristian.org/index.php/blog/four-year-study-confirms-that-imaging-the-eye-with-oct-provides-window-to-ms-progression-in-the-brain-and-a-way-to-track-the-effects-of-therapies

Results 1 - 20 of 121